Approval · Notice of Compliance 2620 · 2001
TRAVATAN: Notice of Compliance 2620
Issued November 9, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2620
- Date
- November 9, 2001
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Elevated intraocular pressure therapy - prostaglandin F2 analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRAVATAN | 02244896 | Cancelled Post Market |
Medicinal ingredients
- TRAVOPROST 0.004 PER